Recombinant human factor VIII/F8 Protein

Specification

• Cat#: VAC-0224
• Product Name: Recombinant human factor VIII/F8 Protein
• Cas No: 9001-27-8
• Description: Recombinant human factor VIII/F8 protein manufactured by removing the B-domain from factor VIII.
• Sequences: B-domain deleted
• Species: Human
• Purity: >99% by SDS-Page and HPLC analysis
• Endotoxin: <0.001 EU per 1 μg of the peptide by the LAL method
• Storage: Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 2-8 °C for 1 week. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
• Application: Beroctocog alfa is indicated for the prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII (FVIII) deficiency. It is also indicated for surgical/invasive procedures in adult and pediatric patients with von Willebrand Disease in who desmopression is either ineffective or contraindicated. It is not indicated for patients with severe (i.e. type 3) von Willebrand Disease whom are undergoing major surgery.